THIRD SUPPLEMENTAL INDENTUREThird Supplemental Indenture • September 29th, 2014 • Intermune Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 29th, 2014 Company Industry JurisdictionThis Third Supplemental Indenture (“Third Supplemental Indenture”) is dated as of September 29, 2014 among InterMune, Inc., a Delaware corporation (the “Issuer”), Roche Holdings, Inc., a Delaware corporation (the “Parent”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee under the Indenture defined below (the “Trustee”).
FOURTH SUPPLEMENTAL INDENTUREFourth Supplemental Indenture • September 29th, 2014 • Intermune Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 29th, 2014 Company Industry JurisdictionThis Fourth Supplemental Indenture (“Fourth Supplemental Indenture”) is dated as of September 29, 2014 among InterMune, Inc., a Delaware corporation (the “Issuer”), Roche Holdings, Inc., a Delaware corporation (the “Parent”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee under the Indenture defined below (the “Trustee”).